« Back to Record
Verset, G., Borbath, I., Karwal, M., Verslype, C., Van Vlierberghe, H., Kardosh, A., Zagonel, V., Stal, P., Sarker, D., Palmer, D. D., Vogel, A., Edeline, J., Cattan, S., Kudo, M., Cheng, A. L., Ogasawara, S., Daniele, B., Chan, S. L., Knox, J., Qin, S., Siegel, A. A., Chisamore, M., Hatogai, K., Wang, A., Finn, R. R., & Zhu, A. X. (2022). Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial. Clinical cancer research, 28(12), 2547-2554. doi:10.1158/1078-0432.CCR-21-3807
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/346784



